Secondary Logo

Institutional members access full text with Ovid®

A Novel Approach for the Targeted Inhibition of Platelet Activation—Separating the Good From the Bad*

Rossaint, Jan, MD, PHD; Zarbock, Alexander, MD

doi: 10.1097/CCM.0000000000003705
Editorials
Buy

Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany

*See also p. e420.

Supported, in part, by the Deutsche Forschungsgemeinschaft (DFG) (RO4537/2-1, RO4537/3-1, and KFO342/2 to Dr. Rossaint and ZA428/14-1 and ZA428/17-1 to Dr. Zarbock).

Dr. Zarbock’s institution received funding from German Research Foundation, German-Isreal-Research Foundation, DFG, Bundesministerium für Bildung und Forschung, Astute Medial, and Fresenius, and he received funding from Astute Medical, bioMerieux, Fresenius, Braun, Baxter, Ratiopharm, and Amomed. Dr. Rossaint disclosed that he does not have any potential conflicts of interest.

Copyright © by 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.